TLSI(TriSalus Life Sciences, Inc.) · 财务报表

TLSI(TriSalus Life Sciences, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$12.40M$18.51M$29.43M$45.15M
毛利润$10.14M$15.91M$25.33M$38.19M
营业利润−$36.44M−$54.48M−$36.16M−$26.95M
净利润−$47.19M−$59.36M−$30.05M−$39.23M
经营现金流−$32.31M−$50.58M−$40.84M−$18.01M
自由现金流−$32.97M−$51.17M−$41.19M−$18.93M
摊薄每股收益$-161.55$-6.77$-1.31$-1.84

TriSalus Life Sciences, Inc. TLSI